Top Markets
Coin of the day
Allena Pharmaceuticals, Inc. Allena Pharmaceuticals, Inc.

Allena Pharmaceuticals, Inc.

ALNAQ
Classificação em ações #42825
Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on... Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on unearthing, developing, and marketing oral enzyme therapies. These treatments are devised to assist patients in the United States afflicted by uncommon and serious metabolic as well as renal conditions. Central to its pipeline is ALLN-346, an innovative enzyme designed to degrade urate, targeting hyperuricemia and gout in individuals with advanced chronic kidney disease. The company, which commenced operations in 2011 and has its main office in Newton, Massachusetts, made headlines on September 2, 2022, by seeking voluntary reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Preço da ação
$0.000001
Última sincronização: 2023-12-13
Valor de mercado
$23.51
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Allena Pharmaceuticals, Inc. (ALNAQ)

Categoria

Rácio P/B de Allena Pharmaceuticals, Inc. (ALNAQ)
Rácio P/B em 2026 TTM: 0
De acordo com os relatórios financeiros mais recentes e o preço das ações da Allena Pharmaceuticals, Inc., o rácio P/B atual (TTM) é 0. No final de 2026, o rácio P/B era 0.
Histórico do rácio P/B da Allena Pharmaceuticals, Inc. de 2026 a 2026
Rácio P/B no final de cada ano
Ano Rácio P/B Alterar
Não há dados suficientes para as datas fornecidas.
Rácio P/B de empresas semelhantes ou concorrentes
Empresa Rácio P/B Diferença do rácio P/B País
6.2613 -
US
6.3483 -
NL
- -
CH
3.634 -
BE
- -
KR